TGTX — TG Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for TG Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	315	162	218	311	142
Net Total Accounts Receivable
Net Total Receivables	1.39	0	51.1	129	306
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	331	168	318	566	631
Net Property, Plant And Equipment	11.1	10.8	9.56	7.15	6.28
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	380	194	330	578	1,063
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	65.4	53.2	53.7	90.7	154
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	142	135	169	355	415
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	237	58.6	161	222	648
Total Liabilities & Shareholders' Equity	380	194	330	578	1,063
Total Common Shares Outstanding